CARM
Price
$0.19
Change
-$0.03 (-13.64%)
Updated
Apr 3, 04:59 PM (EDT)
Capitalization
9.28M
ESLA
Price
$0.94
Change
+$0.13 (+16.05%)
Updated
Apr 3, 04:44 PM (EDT)
Capitalization
27.49M
Ad is loading...

CARM vs ESLA

Header iconCARM vs ESLA Comparison
Open Charts CARM vs ESLABanner chart's image
Carisma Therapeutics
Price$0.19
Change-$0.03 (-13.64%)
Volume$681
Capitalization9.28M
Estrella Immunopharma
Price$0.94
Change+$0.13 (+16.05%)
Volume$100
Capitalization27.49M
CARM vs ESLA Comparison Chart
Loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CARM vs. ESLA commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARM is a Buy and ESLA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (CARM: $0.22 vs. ESLA: $0.81)
Brand notoriety: CARM and ESLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CARM: 187% vs. ESLA: 52%
Market capitalization -- CARM: $8.03M vs. ESLA: $29.33M
CARM [@Biotechnology] is valued at $8.03M. ESLA’s [@Biotechnology] market capitalization is $29.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARM’s FA Score shows that 0 FA rating(s) are green whileESLA’s FA Score has 0 green FA rating(s).

  • CARM’s FA Score: 0 green, 5 red.
  • ESLA’s FA Score: 0 green, 5 red.
According to our system of comparison, both CARM and ESLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARM’s TA Score shows that 4 TA indicator(s) are bullish while ESLA’s TA Score has 4 bullish TA indicator(s).

  • CARM’s TA Score: 4 bullish, 5 bearish.
  • ESLA’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both CARM and ESLA are a bad buy in the short-term.

Price Growth

CARM (@Biotechnology) experienced а -42.30% price change this week, while ESLA (@Biotechnology) price change was -17.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.57%. For the same industry, the average monthly price growth was -10.69%, and the average quarterly price growth was -14.76%.

Reported Earning Dates

CARM is expected to report earnings on May 15, 2023.

ESLA is expected to report earnings on Mar 14, 2023.

Industries' Descriptions

@Biotechnology (-8.57% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLA($27.5M) has a higher market cap than CARM($9.28M). ESLA YTD gains are higher at: -32.417 vs. CARM (-46.944). ESLA has higher annual earnings (EBITDA): -8.82M vs. CARM (-63.37M). CARM has more cash in the bank: 26.9M vs. ESLA (1.8M). CARM has higher revenues than ESLA: CARM (20.3M) vs ESLA (0).
CARMESLACARM / ESLA
Capitalization9.28M27.5M34%
EBITDA-63.37M-8.82M719%
Gain YTD-46.944-32.417145%
P/E RatioN/AN/A-
Revenue20.3M0-
Total Cash26.9M1.8M1,496%
Total Debt3.32MN/A-
FUNDAMENTALS RATINGS
CARM: Fundamental Ratings
CARM
OUTLOOK RATING
1..100
62
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
32

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CARMESLA
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
57%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
54%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
43%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 18 days ago
84%
Bullish Trend 23 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
72%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Ad is loading...
CARM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ESLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LMFA1.300.03
+2.36%
LM Funding America
OPTN9.160.01
+0.11%
OptiNose Inc
USM69.71N/A
N/A
United States Cellular Corp
SUZ9.33-0.02
-0.21%
Suzano SA
EGY3.80-0.02
-0.52%
Vaalco Energy

ESLA and

Correlation & Price change

A.I.dvisor tells us that ESLA and IONS have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESLA and IONS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLA
1D Price
Change %
ESLA100%
+6.71%
IONS - ESLA
28%
Poorly correlated
+5.32%
IMUX - ESLA
25%
Poorly correlated
+4.23%
CARM - ESLA
25%
Poorly correlated
-3.60%
WINT - ESLA
25%
Poorly correlated
+15.83%
CYTOF - ESLA
23%
Poorly correlated
-2.85%
More